Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer. 2000; 88 :770–776. doi: 10.1002/(SICI)1097-0142(20000215)88:43.0.CO;2-0. [ Cross Ref ]...
本周,致力于研发精准新药用于治疗严重慢性疾病的生物制药公司Lexicon Pharmaceuticals宣布,美国FDA已接受了telotristat etiprate新药申请的优先审评。若通过,telotristat etiprate将是首个被批准用于类癌综合症(carcinoid syndrome)的口服治疗药物。 类癌综合症是一种影响数以千计的神经内分泌瘤(neuroendocrine tumors, NET)...
Read about carcinoid tumor treatment, symptoms, and meaning. Carcinoid tumors in the lungs or gut often have no symptoms, however, they may cause carcinoid syndrome. Learn the symptoms, treatment, and prognosis of carcinoid tumors.
Long-Term Management of the Carcinoid Syndrome Treatment with octreotide alone and in combination with alpha-interferonLong-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)Motor Dysfunction of the Small Bowel and Colon in Patients with the ...
本周,致力于研发精准新药用于治疗严重慢性疾病的生物制药公司Lexicon Pharmaceuticals宣布,美国FDA已接受了telotristat etiprate新药申请的优先审评。若通过,telotristat etiprate将是首个被批准用于类癌综合症(carcinoid syndrome)的口服治疗药物。 类癌综合症是一种影响数以千计的神经内分泌瘤(neuroendocrine tumors, NET)...
摘要: This communication reports the successful management of carcinoid syndrome by transcatheter hepatic artery embolization in a patient who was a poor surgical risk because of the syndrome itself. An elective right hepatectomy was performed 1 month after embolization.关键词:...
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. We studied the effects of a long-acting analogue of somatostatin (SMS 201-995, Sandoz) in 25 patients with histologically proved metastatic carcinoid tumor... L Kvols - 《N Engl J Med》 被引量:...
Treatment of the carcinoid syndrome with SMS 201-995;a somatostatin analogue. Scand J Gastroenterol 1986;119:191-2.Öberg, K., Norheim, I., Lundqvist, G., Wide, L. (1986) Treatment of the carcinoid syndrome with SMS 201-995, a somatostatin analouge. Scand J Gastroenterol 119: pp. 191...
In addition to providing effective symptom relief in malignant carcinoid syndrome, octreotide can also be used for diagnostic purposes. Despite its expense, octreotide is the current agent of choice for the treatment of this condition. Analogues with different receptor specificities and pharmacokinetics ...
Included in this report is a brief summary of the carcinoid syndrome based on a case history of a patient followed from diagnosis to death and post-mortem examination. The current status of treatment of this condition is discussed. Get PDF (538K) More content like this Find more content: ...